33 results
343 |
Applicability of Spatial Technology in Cancer Research
Sangjeong Ahn, Hye Seung Lee
KMSID: 1516086677 Cancer Res Treat. 2024;56(2):343-356. Published online 2024 January 30 DOI: http://dx.doi.org/10.4143/crt.2023.1302 | |
357 |
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021
Eun Hye Park, Kyu-Won Jung, Nam Ju Park, Mee Joo Kang, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
KMSID: 1516086700 Cancer Res Treat. 2024;56(2):357-371. Published online 2024 March 13 DOI: http://dx.doi.org/10.4143/crt.2024.253 | |
372 |
Prediction of Cancer Incidence and Mortality in Korea, 2024
Kyu-Won Jung, Mee Joo Kang, Eun Hye Park, E Hwa Yun, Hye-Jin Kim, Jeong-Eun Kim, Hyun-Joo Kong, Jeong-Soo Im, Hong Gwan Seo
KMSID: 1516086699 Cancer Res Treat. 2024;56(2):372-379. Published online 2024 March 11 DOI: http://dx.doi.org/10.4143/crt.2024.252 | |
380 |
Health Inequities in Cancer Incidence According to Economic Status and Regions Are Still Existed Even under Universal Health Coverage System in Korea: A Nationwide Population Based Study Using the National Health Insurance Database
Youngs Chang, Soo-Hee Hwang, Sang-A Cho, Hyejin Lee, Eunbyul Cho, Jin Yong Lee
KMSID: 1516086678 Cancer Res Treat. 2024;56(2):380-403. Published online 2023 December 6 DOI: http://dx.doi.org/10.4143/crt.2023.650 | |
404 |
Impact of Patient Sex on Adverse Events and Unscheduled Utilization of Medical Services in Cancer Patients Undergoing Adjuvant Chemotherapy: A Multicenter Retrospective Cohort Study
Songji Choi, Seyoung Seo, Ju Hyun Lee, Koung Jin Suh, Ji-Won Kim, Jin Won Kim, Se Hyun Kim, Yu Jung Kim, Keun-Wook Lee, Jwa Hoon Kim, Tae Won Kim, Yong Sang Hong, Sun Young Kim, Jeong Eun Kim, Sang-We Kim, Dae Ho Lee, Jae Cheol Lee, Chang-Min Choi, Shinkyo Yoon, Su-Jin Koh, Young Joo Min, Yongchel Ahn, Hwa Jung Kim, Jin Ho Baek, Sook Ryun Park, Jee Hyun Kim
KMSID: 1516086685 Cancer Res Treat. 2024;56(2):404-413. Published online 2023 November 7 DOI: http://dx.doi.org/10.4143/crt.2023.784 | |
414 |
Radiation Oncologists’ Perspectives on Oligometastatic Disease: A Korean Survey Study
Chai Hong Rim, Won Kyung Cho, Jong Hoon Lee, Young Seok Kim, Yang-Gun Suh, Kyung Hwan Kim, Ah Ram Chang, Eui Kyu Chie, Yong Chan Ahn
KMSID: 1516086692 Cancer Res Treat. 2024;56(2):414-421. Published online 2023 November 22 DOI: http://dx.doi.org/10.4143/crt.2023.876 | |
422 |
The Real-World Outcome of First Line Atezolizumab in Extensive-Stage Small Cell Lung Cancer: A Multicenter Prospective Cohort Study
Myeong Geun Choi, Yeon Joo Kim, Jae Cheol Lee, Wonjun Ji, In-Jae Oh, Sung Yong Lee, Seong Hoon Yoon, Shin Yup Lee, Jeong Eun Lee, Eun Young Kim, Chang-Min Choi
KMSID: 1516086694 Cancer Res Treat. 2024;56(2):422-429. Published online 2023 October 23 DOI: http://dx.doi.org/10.4143/crt.2023.913 | |
430 |
Intrathoracic Progression Is Still the Most Dominant Failure Pattern after First-Line Chemo-immunotherapy in Extensive-Stage Small-Cell Lung Cancer: Implications for Thoracic Radiotherapy
Dowook Kim, Hak Jae Kim, Hong-Gyun Wu, Joo Ho Lee, Suzy Kim, Tae Min Kim, Jin-Soo Kim, Byoung Hyuck Kim
KMSID: 1516086695 Cancer Res Treat. 2024;56(2):430-441. Published online 2023 November 6 DOI: http://dx.doi.org/10.4143/crt.2023.931 | |
442 |
Genomic Landscape of Pulmonary Sarcomatoid Carcinoma
Hyun Jung Kwon, Sejoon Lee, Yeon Bi Han, Jeonghyo Lee, Soohyeon Kwon, Hyojin Kim, Jin-Haeng Chung
KMSID: 1516086684 Cancer Res Treat. 2024;56(2):442-454. Published online 2023 November 14 DOI: http://dx.doi.org/10.4143/crt.2023.764 | |
455 |
Tissue and Plasma-Based Highly Sensitive Blocker Displacement Amplicon Nanopore Sequencing for EGFR Mutations in Lung Cancer
Patinya Akkhasutthikun, Pornchai Kaewsapsak, Pattaraporn Nimsamer, Pavit Klomkliew, Suthida Visedthorn, Pragwalai Chanchaem, Chinachote Teerapakpinyo, Sunchai Payungporn, Sutima Luangdilok
KMSID: 1516086674 Cancer Res Treat. 2024;56(2):455-463. Published online 2023 November 20 DOI: http://dx.doi.org/10.4143/crt.2023.1108 | |
464 |
Development of the Korean Association for Lung Cancer Clinical Practice Guidelines: Recommendations on Radial Probe Endobronchial Ultrasound for Diagnosing Lung Cancer - An Updated Meta-Analysis
Soo Han Kim, Hyun Sung Chung, Jinmi Kim, Mi-Hyun Kim, Min Ki Lee, Insu Kim, Jung Seop Eom
KMSID: 1516086683 Cancer Res Treat. 2024;56(2):464-483. Published online 2023 November 29 DOI: http://dx.doi.org/10.4143/crt.2023.749 | |
484 |
Revolutionizing Non–Small Cell Lung Cancer Diagnosis: Ultra-High-Sensitive ctDNA Analysis for Detecting Hotspot Mutations with Long-term Stored Plasma
Ji-Young Lee, Seyeon Jeon, Ha Ra Jun, Chang Ohk Sung, Se Jin Jang, Chang-Min Choi, Sung-Min Chun
KMSID: 1516086680 Cancer Res Treat. 2024;56(2):484-501. Published online 2023 October 23 DOI: http://dx.doi.org/10.4143/crt.2023.712 | |
502 |
Clinical Effect of Endosonography on Overall Survival in Patients with Radiological N1 Non–Small Cell Lung Cancer
Bo-Guen Kim, Byeong-Ho Jeong, Goeun Park, Hong Kwan Kim, Young Mog Shim, Sun Hye Shin, Kyungjong Lee, Sang-Won Um, Hojoong Kim, Jong Ho Cho
KMSID: 1516086688 Cancer Res Treat. 2024;56(2):502-512. Published online 2023 December 4 DOI: http://dx.doi.org/10.4143/crt.2023.840 | |
513 |
Pyrotinib Combined with Vinorelbine in Patients with Previously Treated HER2-Positive Metastatic Breast Cancer: A Multicenter, Single-Arm, Prospective Study
Kuikui Jiang, Ruoxi Hong, Wen Xia, Qianyi Lu, Liang Li, Jianhao Huang, Yanxia Shi, Zhongyu Yuan, Qiufan Zheng, Xin An, Cong Xue, Jiajia Huang, Xiwen Bi, Meiting Chen, Jingmin Zhang, Fei Xu, Shusen Wang
KMSID: 1516086686 Cancer Res Treat. 2024;56(2):513-521. Published online 2023 October 12 DOI: http://dx.doi.org/10.4143/crt.2023.786 | |
522 |
Temporal Trend in Uptake of the National General Health Checkups and Cancer Screening Program among Korean Women with Breast Cancer
Thi Xuan Mai Tran, Soyeoun Kim, Chihwan Cha, Boyoung Park
KMSID: 1516086682 Cancer Res Treat. 2024;56(2):522-530. Published online 2023 October 30 DOI: http://dx.doi.org/10.4143/crt.2023.729 | |
531 |
Implication of Pre- and Post-radiotherapy ctDNA Dynamics in Patients with Residual Triple-Negative Breast Cancer at Surgery after Neoadjuvant Chemotherapy: Findings from a Prospective Observational Study
Tae Hoon Lee, Haeyoung Kim, Yeon Jeong Kim, Woong-Yang Park, Won Park, Won Kyung Cho, Nalee Kim
KMSID: 1516086696 Cancer Res Treat. 2024;56(2):531-537. Published online 2023 November 10 DOI: http://dx.doi.org/10.4143/crt.2023.996 | |
538 |
Genomic Characteristics and Its Therapeutic Implications in Breast Cancer Patients with Detectable Molecular Residual Disease
Shu Zhang, Yan Jiang, Lu Zhou, Jing Xu, Gang Zhang, Lu Shen, Yan Xu
KMSID: 1516086670 Cancer Res Treat. 2024;56(2):538-548. Published online 2023 December 5 DOI: http://dx.doi.org/10.4143/crt.2023.1059 | |
549 |
Assessment of Eligibility and Utilization of Accelerated Partial Breast Irradiation in Korean Breast Cancer Patients (KROG 22-15)
Seok-Joo Chun, Ji Hwan Jo, Yong Bae Kim, Sangjoon Park, Sung-Ja Ahn, Su Ssan Kim, Kyubo Kim, Kyung Hwan Shin
KMSID: 1516086676 Cancer Res Treat. 2024;56(2):549-556. Published online 2023 December 8 DOI: http://dx.doi.org/10.4143/crt.2023.1109 | |
557 |
PD-L1 (SP142) Expression in Primary and Recurrent/Metastatic Triple-Negative Breast Cancers and Its Clinicopathological Significance
Eun Kyung Han, Ji Won Woo, Koung Jin Suh, Se Hyun Kim, Jee Hyun Kim, So Yeon Park
KMSID: 1516086669 Cancer Res Treat. 2024;56(2):557-566. Published online 2023 December 12 DOI: http://dx.doi.org/10.4143/crt.2023.1025 | |
567 |
Neoadjuvant Nivolumab Therapy for Esophageal Squamous Cell Carcinoma: A Single-Arm, Phase II Study
Sehhoon Park, Yurimi Lee, Jiyun Lee, Yang Won Min, Hong Kwan Kim, Joon Young Choi, Hyun Ae Jung, Yong Soo Choi, Yoon-La Choi, Young Mog Shim, Jong-Mu Sun
KMSID: 1516086693 Cancer Res Treat. 2024;56(2):567-579. Published online 2023 October 16 DOI: http://dx.doi.org/10.4143/crt.2023.897 | |
580 |
NESC Multicenter Phase II Trial in the Preoperative Treatment of Gastric Adenocarcinoma with Chemotherapy (Docetaxel-Cisplatin-5FU+Lenograstim) Followed by Chemoradiation Based 5FU and Oxaliplatin and Surgery
Laurent Mineur, Frederi Plat, Françoise Desseigne, Gael Deplanque, Mohamed Belkacemi, Laurence Moureau-Zabotto, Carlos D. Beyrne, Khadija Jalali, Stéphane Obled, Denis Smith, Léa Vazquez, Rania Boustany
KMSID: 1516086687 Cancer Res Treat. 2024;56(2):580-589. Published online 2023 October 5 DOI: http://dx.doi.org/10.4143/crt.2023.812 | |
590 |
A Phase 1b/2a Study of GC1118 with 5-Fluorouracil, Leucovorin and Irinotecan (FOLFIRI) in Patients with Recurrent or Metastatic Colorectal Cancer
Keun-Wook Lee, Sae-Won Han, Tae Won Kim, Joong Bae Ahn, Ji Yeon Baek, Sang Hee Cho, Howard Lee, Jin Won Kim, Ji-Won Kim, Tae-You Kim, Yong Sang Hong, Seung-Hoon Beom, Yongjun Cha, Yoonjung Choi, Seonhui Kim, Yung-Jue Bang
KMSID: 1516086675 Cancer Res Treat. 2024;56(2):590-601. Published online 2023 December 7 DOI: http://dx.doi.org/10.4143/crt.2023.1117 | |
602 |
A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer
Ting Liu, Qing Li, Zhen Lin, Chunhua Liu, Wei Pu, Shasha Zeng, Jun Lai, Xuebin Cai, Lisha Zhang, Shuyang Wang, Miao Chen, Wei Cao, Hongfeng Gou, Qing Zhu
KMSID: 1516086681 Cancer Res Treat. 2024;56(2):602-615. Published online 2023 October 12 DOI: http://dx.doi.org/10.4143/crt.2023.726 | |
616 |
Physical Activity and Bladder Cancer Risk: Findings of the Japan Collaborative Cohort Study
Hang An, Keyang Liu, Kokoro Shirai, Ryo Kawasaki, Akiko Tamakoshi, Hiroyasu Iso
KMSID: 1516086698 Cancer Res Treat. 2024;56(2):616-623. Published online 2023 October 6 DOI: http://dx.doi.org/10.4143/crt.2023.962 | |
624 |
Clinical Outcomes of Small Cell Carcinoma of the Genitourinary Tract and the Prognostic Significance of the Tumor Immune Microenvironment
Jaewon Hyung, Hyung-Don Kim, Gi Hwan Kim, Yong Mee Cho, Yeon-Mi Ryu, Sang-Yeob Kim, Inkeun Park, Shinkyo Yoon, Jae Lyun Lee
KMSID: 1516086673 Cancer Res Treat. 2024;56(2):624-633. Published online 2023 November 29 DOI: http://dx.doi.org/10.4143/crt.2023.1076 | |
634 |
Oncological Outcomes in Men with Metastatic Castration-Resistant Prostate Cancer Treated with Enzalutamide with versus without Confirmatory Bone Scan
Chang Wook Jeong, Jang Hee Han, Dong Deuk Kwon, Jae Young Joung, Choung-Soo Kim, Hanjong Ahn, Jun Hyuk Hong, Tae-Hwan Kim, Byung Ha Chung, Seong Soo Jeon, Minyong Kang, Sung Kyu Hong, Tae Young Jung, Sung Woo Park, Seok Joong Yun, Ji Yeol Lee, Seung Hwan Lee, Seok Ho Kang, Cheol Kwak
KMSID: 1516086689 Cancer Res Treat. 2024;56(2):634-641. Published online 2023 December 5 DOI: http://dx.doi.org/10.4143/crt.2023.848 | |
642 |
Tandem High-Dose Chemotherapy Increases the Risk of Secondary Malignant Neoplasm in Pediatric Solid Tumors
Hana Lim, Minji Im, Eun Seop Seo, Hee Won Cho, Hee Young Ju, Keon Hee Yoo, Sung Yoon Cho, Jong-Won Kim, Do Hoon Lim, Ki Woong Sung, Ji Won Lee
KMSID: 1516086697 Cancer Res Treat. 2024;56(2):642-651. Published online 2023 November 24 DOI: http://dx.doi.org/10.4143/crt.2023.999 | |
652 |
Long-term Outcomes of Protocol-Based Treatment for Newly Diagnosed Medulloblastoma
Won Kee Ahn, Seung Min Hahn, Hong In Yoon, Jeongshim Lee, Eun Kyung Park, Kyu Won Shim, Dong Seok Kim, Chang-Ok Suh, Se Hoon Kim, Chuhl Joo Lyu, Jung Woo Han
KMSID: 1516086691 Cancer Res Treat. 2024;56(2):652-664. Published online 2023 November 30 DOI: http://dx.doi.org/10.4143/crt.2023.865 | |
665 |
Case Series of Soft Tissue Sarcoma Patients with Brain Metastasis with Implications from Genomic and Transcriptomic Analysis
Changhee Park, Rokhyun Kim, Jaeyong Choi, Miso Kim, Tae Min Kim, Ilkyu Han, Jong-Il Kim, Han-Soo Kim
KMSID: 1516086690 Cancer Res Treat. 2024;56(2):665-674. Published online 2023 September 27 DOI: http://dx.doi.org/10.4143/crt.2023.864 | |
675 |
A Phase II Study to Evaluate the Efficacy of Bortezomib in Combination with Thalidomide in Treatment-Naïve Waldenstrom Macroglobulinemia Patients
Ja Min Byun, Junghoon Shin, Sang-A Kim, Hyunkyung Park, Jiyun Lee, Dong-Yeop Shin, Junshik Hong, Jeong-Ok Lee, Soo-Mee Bang, Inho Kim, Sung-Soon Yoon, Youngil Koh
KMSID: 1516086679 Cancer Res Treat. 2024;56(2):675-680. Published online 2023 September 25 DOI: http://dx.doi.org/10.4143/crt.2023.681 | |
681 |
Pembrolizumab for Patients with Relapsed or Refractory Extranodal NK/T-Cell Lymphoma in Korea
Ji Yun Lee, Ji Hyun Kwon, Joon Young Hur, Jun Ho Yi, Ji Hyun Lee, Hyungwoo Cho, Young Rok Do, Jae-Cheol Jo, Hye Jin Kang, Yougil Koh, Won Sik Lee, Sung Nam Lim, Sang Eun Yoon, Seok Jin Kim, Jeong-Ok Lee
KMSID: 1516086668 Cancer Res Treat. 2024;56(2):681-687. Published online 2023 November 10 DOI: http://dx.doi.org/10.4143/crt.2023.1042 | |
688 |
Assessment of Bone Marrow Involvement in Extranodal NK/T-Cell Lymphoma: Positron Emission Tomography versus Bone Marrow Biopsy, and the Significance of Minimal Involvement by EBV+ Cells (KROG 18-09)
Tae Hoon Lee, Hyun Ju Kim, Jong Hoon Lee, Jeongshim Lee, Jin Hee Kim, Dongryul Oh, Keun-Yong Eom
KMSID: 1516086671 Cancer Res Treat. 2024;56(2):688-696. Published online 2023 December 11 DOI: http://dx.doi.org/10.4143/crt.2023.1049 | |
697 |
RETRACTION: Circular RNA-ZFR Inhibited Cell Proliferation and Promoted Apoptosis in Gastric Cancer by Sponging miR-130a/miR-107 and Modulating PTEN
KMSID: 1516086672 Cancer Res Treat. 2024;56(2):697-697. Published online 2024 February 20 DOI: http://dx.doi.org/10.4143/crt.2017.537.RE | |